Download PDF
Thromb Haemost 2015; 114(03): 651-652
DOI: 10.1160/TH15-02-0156
Letters to the Editor
Schattauer GmbH

Limited evidence for diagnosing and treating “non-criteria obstetric antiphospholipid syndrome”

Guilherme Ramires de Jesus
1   Department of Obstetrics. Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
,
Roger Abramino Levy
2   Department of Rheumatology. Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil
,
T. Flint Porter
3   Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA
4   Intermountain Healthcare, Salt Lake City, Utah, USA
,
D. Ware Branch
3   Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA
4   Intermountain Healthcare, Salt Lake City, Utah, USA
› Author Affiliations
Further Information

Publication History

Received: 19 February 2015

Accepted after minor revision: 25 March 2015

Publication Date:
01 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Arachchillage DR, Machin SJ, Mackie IJ. et al. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome. Thromb Haemost 2015; 113: 13-19.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Miyakis S, Lockshin MD, Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 04: 295-306.
    CrossrefPubMedGoogle Scholar
  • 3 de Jesus GR, Agmon-Levin N, Andrade CA. et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric anti-phospholipid syndrome. Autoimmun Rev 2014; 13: 795-813.
    CrossrefPubMedGoogle Scholar
  • 4 Mekinian A, Loire-Berson P, Nicaise-Roland P. et al. Outcomes and treatment of obstetrical anti-phospholipid syndrome in women with low anti-phospholipid antibody levels. J Reprod Immunol 2012; 94: 222-226.
    CrossrefPubMedGoogle Scholar
  • 5 Simchen MJ, Dulitzki M, Rofe G. et al. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome. Acta Obstet Gynecol Scand 2011; 90: 1428-1433.
    CrossrefPubMedGoogle Scholar
  • 6 Farquharson RG, Quenby S, Greaves M. Anti-phospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002; 100: 408-413.
    PubMedGoogle Scholar
  • 7 Laskin CA, Spitzer KA, Clark CA. et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009; 36: 279-287.
    CrossrefPubMedGoogle Scholar
  • 8 Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996; 174: 1584-1589.
    CrossrefPubMedGoogle Scholar
  • 9 Rai R, Cohen H, Dave M. et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or anti-phospholipid antibodies). Br Med J 1997; 314: 253-257.
    CrossrefPubMedGoogle Scholar
  • 10 Sugiura-Ogasawara M, Ozaki Y, Katano K. et al. Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage. Hum Reprod 2012; 27: 2297-2303.
    CrossrefPubMedGoogle Scholar
  • 11 Grande M, Borrell A, Garcia-Posada R. et al. The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage. Hum Reprod 2012; 27: 3109-3117.
    CrossrefPubMedGoogle Scholar
  • 12 de Jong PG, Kaandorp S, Di Nisio M. et al. Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 2014; 07: CD004734.
    PubMedGoogle Scholar
  • 13 Practice Committee of American Society for Reproductive Medicine.. Anti-phospholipid antibodies do not affect IVF success. Fertil Steril 2008; 90 (Suppl. 05) S172-173.
    CrossrefPubMedGoogle Scholar